,0
zip,01887
sector,Healthcare
fullTimeEmployees,18600
longBusinessSummary,"Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts."
city,Wilmington
phone,781 222 6000
state,MA
country,United States
companyOfficers,[]
website,https://www.criver.com
maxAge,1
address1,251 Ballardvale Street
industry,Diagnostics & Research
ebitdaMargins,0.25421
profitMargins,0.11043999
grossMargins,0.3778
operatingCashflow,760798976
revenueGrowth,0.144
operatingMargins,0.1792
ebitda,899926976
targetLowPrice,350
recommendationKey,buy
grossProfits,1337470000
freeCashflow,630665152
targetMedianPrice,390
currentPrice,279.1
earningsGrowth,-0.049
currentRatio,1.233
returnOnAssets,0.06336
numberOfAnalystOpinions,11
targetMeanPrice,391
debtToEquity,113.912
returnOnEquity,0.16844
targetHighPrice,440
totalCash,242276992
totalDebt,2952598016
totalRevenue,3540160000
totalCashPerShare,4.799
financialCurrency,USD
revenuePerShare,70.391
quickRatio,0.857
recommendationMean,1.6
exchange,NYQ
shortName,Charles River Laboratories Inte
longName,"Charles River Laboratories International, Inc."
exchangeTimezoneName,America/New_York
exchangeTimezoneShortName,EDT
isEsgPopulated,False
gmtOffSetMilliseconds,-14400000
quoteType,EQUITY
symbol,CRL
messageBoardId,finmb_91093
market,us_market
annualHoldingsTurnover,
enterpriseToRevenue,4.762
beta3Year,
enterpriseToEbitda,18.733
52WeekChange,-0.0136066675
morningStarRiskRating,
forwardEps,13.41
revenueQuarterlyGrowth,
sharesOutstanding,50486000
fundInceptionDate,
annualReportExpenseRatio,
totalAssets,
bookValue,50.214
sharesShort,1058458
sharesPercentSharesOut,0.021
fundFamily,
lastFiscalYearEnd,1640390400
heldPercentInstitutions,0.95125
netIncomeToCommon,390982016
trailingEps,7.6
lastDividendValue,
SandP52WeekChange,0.14403355
priceToBook,5.558211
heldPercentInsiders,0.01539
nextFiscalYearEnd,1703462400
yield,
mostRecentQuarter,1640390400
shortRatio,1.47
sharesShortPreviousMonthDate,1644883200
floatShares,49924642
beta,1.241141
enterpriseValue,16858148864
priceHint,2
threeYearAverageReturn,
lastSplitDate,
lastSplitFactor,
legalType,
lastDividendDate,
morningStarOverallRating,
earningsQuarterlyGrowth,-0.039
priceToSalesTrailing12Months,3.9802275
dateShortInterest,1647302400
pegRatio,1.43
ytdReturn,
forwardPE,20.812826
lastCapGain,
shortPercentOfFloat,0.026800001
sharesShortPriorMonth,1083791
impliedSharesOutstanding,0
category,
fiveYearAverageReturn,
previousClose,281.05
regularMarketOpen,282.77
twoHundredDayAverage,372.3772
trailingAnnualDividendYield,0
payoutRatio,0
volume24Hr,
regularMarketDayHigh,283.06
navPrice,
averageDailyVolume10Day,481140
regularMarketPreviousClose,281.05
fiftyDayAverage,304.2184
trailingAnnualDividendRate,0
open,282.77
toCurrency,
averageVolume10days,481140
expireDate,
algorithm,
dividendRate,
exDividendDate,
circulatingSupply,
startDate,
regularMarketDayLow,273
currency,USD
trailingPE,36.723686
regularMarketVolume,340272
lastMarket,
maxSupply,
openInterest,
marketCap,14090642432
volumeAllCurrencies,
strikePrice,
averageVolume,513441
dayLow,273
ask,280.31
askSize,800
volume,340272
fiftyTwoWeekHigh,460.21
fromCurrency,
fiveYearAvgDividendYield,
fiftyTwoWeekLow,251.3
bid,277.98
tradeable,False
dividendYield,
bidSize,1300
dayHigh,283.06
regularMarketPrice,279.1
preMarketPrice,
logo_url,https://logo.clearbit.com/criver.com
